[1] |
Zawerton A, Mignot C, Sigafoos A, et al. Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency[J]. Genet Med, 2020, 22(3):524-537.
doi: 10.1038/s41436-019-0657-0
pmid: 31578471
|
[2] |
中华医学会儿科学分会内分泌遗传代谢学组. 矮身材儿童诊治指南[J]. 中华儿科杂志, 2008, 46(6):428-430.
|
|
Endocrine Genetics and Metabolism Group of Pediatrics Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of short stature children[J]. Chinese Journal of Pediatrics. 2008; 58(6):443-446.
|
[3] |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-524.
doi: 10.1038/gim.2015.30
pmid: 25741868
|
[4] |
Schanze I, Schanze D, Bacino CA, et al. Haploinsufficiency of SOX5, a member of the SOX (SRY-related HMG-box) family of transcription factors is a cause of intellectual disability[J]. Eur J Med Genet, 2013, 56(2):108-113.
doi: 10.1016/j.ejmg.2012.11.001
pmid: 23220431
|
[5] |
Lamb AN, Rosenfeld JA, Neill NJ, et al. Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features[J]. Hum Mutat, 2012, 33(4):728-740.
doi: 10.1002/humu.22037
URL
|
[6] |
Fukushi D, Yamada K, Suzuki K, et al. Clinical and genetic characterization of a patient with SOX5 haploinsufficiency caused by a de novo balanced reciprocal translocation[J]. Gene, 2018, 655:65-70.
doi: 10.1016/j.gene.2018.02.049
URL
|
[7] |
Lee RW, Bodurtha J, Cohen J, et al. Deletion 12p12 involving SOX5 in two children with developmental delay and dysmorphic features[J]. Pediatr Neurol, 2013, 48(4):317-320.
doi: 10.1016/j.pediatrneurol.2012.12.013
URL
|
[8] |
Quintela I, Barros F, Lago-Leston R, et al. A maternally inherited 16p13.11-p12.3 duplication concomitant with a de novo SOX5 deletion in a male patient with global developmental delay, disruptive and obsessive behaviors and minor dysmorphic features[J]. Am J Med Genet A, 2015, 167(6):1315-1322.
doi: 10.1002/ajmg.a.36909
pmid: 25847113
|
[9] |
Nesbitt A, Bhoj EJ, McDonald Gibson K, et al. Exome sequencing expands the mechanism of SOX5-associated intellectual disability: A case presentation with review of sox-related disorders[J]. Am J Med Genet A, 2015, 167A(11):2548-2554.
doi: 10.1002/ajmg.a.37221
pmid: 26111154
|
[10] |
Zech M, Poustka K, Boesch S, et al. SOX5-Null Heterozygous Mutation in a Family with Adult-Onset Hyperkinesia and Behavioral Abnormalities[J]. Case Rep Genet, 2017, 2017:2721615.
|
[11] |
Gkirgkinoudis A, Tatsi C, DeWard SJ, et al. A SOX5gene variant as a possible contributor to short stature[J]. Endocrinol Diabetes Metab Case Rep, 2020, 2020:20-0133.
|
[12] |
Innella G, Greco D, Carli D, et al. Clinical spectrum and follow-up in six individuals with Lamb-Shaffer syndrome (SOX5)[J]. Am J Med Genet A, 2021, 185(2):608-613.
doi: 10.1002/ajmg.a.62001
URL
|
[13] |
曹井贺, 李建伟, 张玉芹, 等. 一例Lamb-Shaffer综合征患者的 SOX5基因变异分析[J]. 中华医学遗传学杂志, 2021, 38(8):765-767.
|
|
Cao JH, Li JW, Zhang YQ, et al. Variant analysis of SOX5 gene in a Lamb-Shaffer syndrome family[J]. Chinese Journal of Medical Genetics, 2021, 38(8):765-767.
|
[14] |
Schepers GE, Teasdale RD, Koopman P. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families[J]. Dev Cell, 2002, 3(2):167-170.
pmid: 12194848
|
[15] |
Ikeda T, Zhang J, Chano T, et al. Identification and characterization of the human long form of Sox5 (L-SOX5) gene[J]. Gene, 2002, 298(1):59-68.
doi: 10.1016/S0378-1119(02)00927-7
URL
|
[16] |
Kiselak EA, Shen X, Song J, et al. Transcriptional regulation of an axonemal central apparatus gene, sperm-associated antigen 6, by a SRY-related high mobility group transcription factor, S-SOX5[J]. J Biol Chem, 2010, 285(40):30496-30505.
doi: 10.1074/jbc.M110.121590
URL
|
[17] |
Wunderle VM, Critcher R, Ashworth A, et al. Cloning and characterization of SOX5, a new member of the human SOX gene family[J]. Genomics, 1996, 36(2):354-358.
pmid: 8812465
|
[18] |
Besenbacher S, Sulem P, Helgason A, et al. Multi-nucleotide de novo Mutations in Humans[J]. PLoS Genet, 2016, 12(11):e1006315.
doi: 10.1371/journal.pgen.1006315
URL
|
[19] |
Lu HY, Cui YX, Shi YC, et al. A girl with distinctive features of borderline high blood pressure, short stature, characteristic brachydactyly, and 11.47 Mb deletion in 12p11.21-12p12.2 by oligonucleotide array CGH[J]. Am J Med Genet A, 2009, 149A(10):2321-2323.
doi: 10.1002/ajmg.a.33030
URL
|
[20] |
Klopocki E, Hennig BP, Dathe K, et al. Deletion and point mutations of PTHLH cause brachydactyly type E[J]. Am J Hum Genet, 2010, 86(3):434-439.
doi: 10.1016/j.ajhg.2010.01.023
pmid: 20170896
|
[21] |
Martinez-Morales PL, Quiroga AC, Barbas JA, et al. SOX5 5 controls cell cycle progression in neural progenitors by interfering with the WNT-beta-catenin pathway[J]. EMBO Rep, 2010, 11(6):466-472.
doi: 10.1038/embor.2010.61
pmid: 20448664
|
[22] |
Shiseki M, Masuda A, Yoshinaga K, et al. Identification of the SOX5 gene as a novel IGH-involved translocation partner in BCL2-negative follicular lymphoma with t(12;14)(p12.2;q32)[J]. Int J Hematol, 2015, 102(5):633-638.
doi: 10.1007/s12185-015-1823-z
URL
|
[23] |
Seifert MB, Olesen MS, Christophersen IE, et al. Genetic variants on chromosomes 7p31 and 12p12 are associated with abnormal atrial electrical activation in patients with early-onset lone atrial fibrillation[J]. Ann Noninvasive Electrocardiol, 2019, 24(6):e12661.
|
[24] |
Zhang L, Xu X, Chen Y, et al. Mapping of developmental dysplasia of the hip to two novel regions at 8q23-q24 and 12p12[J]. Exp Ther Med, 2020, 19(4):2799-2803.
|
[25] |
Perdomo S, Anantharaman D, Foll M, et al. Genomic analysis of head and neck cancer cases from two high incidence regions[J]. PLoS One, 2018, 13(1):e0191701.
doi: 10.1371/journal.pone.0191701
URL
|
[26] |
Grant TJ, Mehta AK, Gupta A, et al. STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines[J]. Oncotarget, 2017, 8(45):78556-78572.
doi: 10.18632/oncotarget.20833
URL
|
[27] |
Huang H, Shen H, Wang Y, et al. LOH12CR1 is a novel tumor suppressor inhibiting tumor growth through dere-gulation of G1/S checkpoint in human colorectal carcinoma[J]. Curr Mol Med, 2018, 18(1):25-35.
doi: 10.2174/1566524018666180608084005
pmid: 29879888
|
[28] |
Yeh CN, Chen MH, Chang YC, et al. Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinoma[J]. Mol Carcinog, 2019, 58(2):270-278.
doi: 10.1002/mc.22925
URL
|